Japan

Japan

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3.04 (2.67 - 3.37) 2019 Modelled IHME
3.04 (2.67 - 3.37) 2018 Modelled IHME
3.04 (2.67 - 3.38) 2017 Modelled IHME
3.04 (2.69 - 3.37) 2016 Modelled IHME
3.06 (2.69 - 3.38) 2015 Modelled IHME
3.07 (2.70 - 3.39) 2014 Modelled IHME
3.08 (2.72 - 3.40) 2013 Modelled IHME
3.09 (2.72 - 3.41) 2012 Modelled IHME
3.1 (2.73 - 3.42) 2011 Modelled IHME
3.11 (2.75 - 3.44) 2010 Modelled IHME
3.13 (2.77 - 3.46) 2009 Modelled IHME
3.15 (2.79 - 3.49) 2008 Modelled IHME
3.18 (2.81 - 3.51) 2007 Modelled IHME
3.2 (2.83 - 3.54) 2006 Modelled IHME
3.21 (2.85 - 3.56) 2005 Modelled IHME
3.22 (2.85 - 3.57) 2004 Modelled IHME
3.23 (2.86 - 3.57) 2003 Modelled IHME
3.23 (2.87 - 3.57) 2002 Modelled IHME
3.24 (2.88 - 3.58) 2001 Modelled IHME
3.24 (2.89 - 3.58) 2000 Modelled IHME
3.26 (2.90 - 3.60) 1999 Modelled IHME
3.27 (2.92 - 3.63) 1998 Modelled IHME
3.29 (2.94 - 3.65) 1997 Modelled IHME
3.3 (2.95 - 3.66) 1996 Modelled IHME
3.31 (2.96 - 3.66) 1995 Modelled IHME
3.31 (2.96 - 3.66) 1994 Modelled IHME
3.3 (2.95 - 3.65) 1993 Modelled IHME
3.3 (2.94 - 3.65) 1992 Modelled IHME
3.29 (2.92 - 3.64) 1991 Modelled IHME
3.28 (2.90 - 3.63) 1990 Modelled IHME
1.97 (1.56 - 2.45) 2015 Modelled WHO
1.02 (1.01 - 1.02) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.08 (0.06 - 0.10) 2019 Modelled IHME
0.08 (0.07 - 0.11) 2018 Modelled IHME
0.09 (0.07 - 0.11) 2017 Modelled IHME
0.59 (0.47 - 0.74) 2016 Modelled IHME
1.09 (0.87 - 1.37) 2015 Modelled IHME
1.1 (0.88 - 1.38) 2014 Modelled IHME
1.11 (0.88 - 1.39) 2013 Modelled IHME
1.11 (0.89 - 1.39) 2012 Modelled IHME
1.11 (0.89 - 1.40) 2011 Modelled IHME
1.11 (0.89 - 1.40) 2010 Modelled IHME
1.12 (0.89 - 1.41) 2009 Modelled IHME
1.12 (0.89 - 1.41) 2008 Modelled IHME
1.13 (0.89 - 1.42) 2007 Modelled IHME
1.13 (0.89 - 1.42) 2006 Modelled IHME
1.13 (0.89 - 1.42) 2005 Modelled IHME
1.13 (0.89 - 1.42) 2004 Modelled IHME
1.13 (0.89 - 1.42) 2003 Modelled IHME
1.13 (0.89 - 1.42) 2002 Modelled IHME
1.13 (0.89 - 1.43) 2001 Modelled IHME
1.13 (0.89 - 1.43) 2000 Modelled IHME
1.14 (0.90 - 1.43) 1999 Modelled IHME
1.14 (0.91 - 1.44) 1998 Modelled IHME
1.15 (0.92 - 1.45) 1997 Modelled IHME
1.16 (0.92 - 1.47) 1996 Modelled IHME
1.16 (0.93 - 1.47) 1995 Modelled IHME
1.16 (0.93 - 1.46) 1994 Modelled IHME
1.17 (0.93 - 1.47) 1993 Modelled IHME
1.17 (0.93 - 1.46) 1992 Modelled IHME
1.17 (0.93 - 1.47) 1991 Modelled IHME
1.17 (0.93 - 1.47) 1990 Modelled IHME
1.95 (1.50 - 2.53) 2015 Modelled WHO
0.17 2010 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
5.99 (5.07 - 6.85) 2019 Modelled IHME
5.64 (4.81 - 6.40) 2018 Modelled IHME
5.42 (4.62 - 6.15) 2017 Modelled IHME
5.46 (4.66 - 6.17) 2016 Modelled IHME
5.51 (4.72 - 6.23) 2015 Modelled IHME
5.55 (4.76 - 6.26) 2014 Modelled IHME
5.57 (4.79 - 6.28) 2013 Modelled IHME
5.58 (4.83 - 6.27) 2012 Modelled IHME
5.58 (4.83 - 6.26) 2011 Modelled IHME
5.54 (4.82 - 6.21) 2010 Modelled IHME
5.53 (4.84 - 6.18) 2009 Modelled IHME
5.56 (4.89 - 6.19) 2008 Modelled IHME
5.57 (4.94 - 6.16) 2007 Modelled IHME
5.6 (4.99 - 6.17) 2006 Modelled IHME
5.71 (5.11 - 6.29) 2005 Modelled IHME
5.78 (5.20 - 6.36) 2004 Modelled IHME
5.96 (5.37 - 6.56) 2003 Modelled IHME
6.12 (5.54 - 6.73) 2002 Modelled IHME
6.33 (5.75 - 6.94) 2001 Modelled IHME
6.51 (5.92 - 7.10) 2000 Modelled IHME
6.63 (6.05 - 7.23) 1999 Modelled IHME
6.55 (5.98 - 7.13) 1998 Modelled IHME
6.38 (5.82 - 6.97) 1997 Modelled IHME
6.29 (5.72 - 6.86) 1996 Modelled IHME
6.23 (5.69 - 6.79) 1995 Modelled IHME
5.98 (5.48 - 6.52) 1994 Modelled IHME
5.9 (5.42 - 6.42) 1993 Modelled IHME
5.77 (5.31 - 6.27) 1992 Modelled IHME
5.63 (5.19 - 6.12) 1991 Modelled IHME
5.54 (5.11 - 6.01) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
7,655 (6,475 - 8,750) 2019 Modelled IHME
7,238 (6,162 - 8,203) 2018 Modelled IHME
6,968 (5,940 - 7,908) 2017 Modelled IHME
7,038 (6,006 - 7,954) 2016 Modelled IHME
7,121 (6,101 - 8,054) 2015 Modelled IHME
7,187 (6,166 - 8,105) 2014 Modelled IHME
7,227 (6,214 - 8,142) 2013 Modelled IHME
7,241 (6,271 - 8,145) 2012 Modelled IHME
7,251 (6,279 - 8,138) 2011 Modelled IHME
7,211 (6,265 - 8,082) 2010 Modelled IHME
7,195 (6,297 - 8,035) 2009 Modelled IHME
7,230 (6,363 - 8,047) 2008 Modelled IHME
7,243 (6,425 - 8,008) 2007 Modelled IHME
7,276 (6,484 - 8,010) 2006 Modelled IHME
7,410 (6,640 - 8,164) 2005 Modelled IHME
7,505 (6,750 - 8,255) 2004 Modelled IHME
7,728 (6,967 - 8,498) 2003 Modelled IHME
7,919 (7,168 - 8,719) 2002 Modelled IHME
8,182 (7,428 - 8,970) 2001 Modelled IHME
8,397 (7,633 - 9,160) 2000 Modelled IHME
8,534 (7,795 - 9,309) 1999 Modelled IHME
8,416 (7,682 - 9,170) 1998 Modelled IHME
8,186 (7,471 - 8,935) 1997 Modelled IHME
8,046 (7,322 - 8,777) 1996 Modelled IHME
7,948 (7,265 - 8,663) 1995 Modelled IHME
7,612 (6,976 - 8,301) 1994 Modelled IHME
7,493 (6,887 - 8,155) 1993 Modelled IHME
7,304 (6,728 - 7,943) 1992 Modelled IHME
7,108 (6,556 - 7,724) 1991 Modelled IHME
6,971 (6,436 - 7,565) 1990 Modelled IHME
19,893 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
10 (8 - 12) 2019 Modelled IHME
10 (8 - 11) 2018 Modelled IHME
9 (8 - 11) 2017 Modelled IHME
10 (8 - 11) 2016 Modelled IHME
10 (9 - 12) 2015 Modelled IHME
10 (9 - 12) 2014 Modelled IHME
10 (9 - 12) 2013 Modelled IHME
10 (9 - 12) 2012 Modelled IHME
11 (9 - 12) 2011 Modelled IHME
11 (9 - 12) 2010 Modelled IHME
11 (9 - 13) 2009 Modelled IHME
11 (9 - 13) 2008 Modelled IHME
11 (9 - 13) 2007 Modelled IHME
11 (9 - 13) 2006 Modelled IHME
11 (10 - 13) 2005 Modelled IHME
11 (10 - 13) 2004 Modelled IHME
11 (10 - 13) 2003 Modelled IHME
12 (10 - 14) 2002 Modelled IHME
12 (10 - 14) 2001 Modelled IHME
12 (11 - 14) 2000 Modelled IHME
12 (11 - 14) 1999 Modelled IHME
13 (11 - 15) 1998 Modelled IHME
13 (11 - 15) 1997 Modelled IHME
13 (11 - 15) 1996 Modelled IHME
13 (12 - 15) 1995 Modelled IHME
14 (12 - 16) 1994 Modelled IHME
14 (12 - 16) 1993 Modelled IHME
14 (12 - 16) 1992 Modelled IHME
14 (13 - 17) 1991 Modelled IHME
15 (13 - 17) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HBV testing policy
Universal
HepB birth dose policy
Yes (for risk groups)
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
HCV testing policy
Universal
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.45 (0.29 - 0.63) 2019 Modelled IHME
0.45 (0.29 - 0.63) 2018 Modelled IHME
0.44 (0.28 - 0.62) 2017 Modelled IHME
0.41 (0.28 - 0.57) 2016 Modelled IHME
0.39 (0.27 - 0.53) 2015 Modelled IHME
0.4 (0.27 - 0.54) 2014 Modelled IHME
0.4 (0.28 - 0.54) 2013 Modelled IHME
0.41 (0.29 - 0.54) 2012 Modelled IHME
0.41 (0.30 - 0.54) 2011 Modelled IHME
0.42 (0.31 - 0.54) 2010 Modelled IHME
0.43 (0.32 - 0.55) 2009 Modelled IHME
0.43 (0.33 - 0.55) 2008 Modelled IHME
0.44 (0.34 - 0.56) 2007 Modelled IHME
0.46 (0.35 - 0.58) 2006 Modelled IHME
0.47 (0.37 - 0.59) 2005 Modelled IHME
0.52 (0.41 - 0.64) 2004 Modelled IHME
0.6 (0.48 - 0.75) 2003 Modelled IHME
0.69 (0.55 - 0.86) 2002 Modelled IHME
0.77 (0.61 - 0.96) 2001 Modelled IHME
0.8 (0.63 - 1) 2000 Modelled IHME
0.79 (0.62 - 0.98) 1999 Modelled IHME
0.77 (0.61 - 0.96) 1998 Modelled IHME
0.75 (0.59 - 0.92) 1997 Modelled IHME
0.72 (0.57 - 0.89) 1996 Modelled IHME
0.7 (0.56 - 0.87) 1995 Modelled IHME
0.69 (0.55 - 0.85) 1994 Modelled IHME
0.69 (0.55 - 0.84) 1993 Modelled IHME
0.68 (0.54 - 0.84) 1992 Modelled IHME
0.67 (0.53 - 0.83) 1991 Modelled IHME
0.67 (0.53 - 0.83) 1990 Modelled IHME
0.7 (0.30 - 0.80) 2015 Modelled Blach et al, 2017
1.1 (0.40 - 1.70) 2014 Modelled Gower et al, 2014
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.5 (0.50 - 2.20) 2014 Modelled Gower et al, 2014
1.5 (0.50 - 2.20) 2014 Modelled Gower et al, 2014
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
64.8 (55 - 74.50) 1994 Modelled Nelson P et al, 2011

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
29.6 (24.90 - 32.40) 2019 Modelled IHME
29.3 (24.50 - 31.90) 2018 Modelled IHME
28.6 (24 - 31.20) 2017 Modelled IHME
28.4 (23.80 - 31) 2016 Modelled IHME
28.2 (23.60 - 30.60) 2015 Modelled IHME
28.3 (23.90 - 30.80) 2014 Modelled IHME
28.6 (24.30 - 31.10) 2013 Modelled IHME
28.9 (24.70 - 31.40) 2012 Modelled IHME
29.2 (25.10 - 31.70) 2011 Modelled IHME
29.2 (25.30 - 31.50) 2010 Modelled IHME
29.3 (25.50 - 31.40) 2009 Modelled IHME
29.7 (26.20 - 31.80) 2008 Modelled IHME
29.9 (26.60 - 32) 2007 Modelled IHME
30 (26.90 - 32) 2006 Modelled IHME
30.2 (27.20 - 32.10) 2005 Modelled IHME
29.8 (27.10 - 31.60) 2004 Modelled IHME
29.6 (26.90 - 31.20) 2003 Modelled IHME
29 (26.60 - 30.60) 2002 Modelled IHME
28.9 (26.60 - 30.40) 2001 Modelled IHME
28.9 (26.70 - 30.40) 2000 Modelled IHME
28.9 (26.80 - 30.40) 1999 Modelled IHME
28.2 (26.20 - 29.60) 1998 Modelled IHME
27 (25.30 - 28.40) 1997 Modelled IHME
26.2 (24.60 - 27.60) 1996 Modelled IHME
25.4 (23.90 - 26.60) 1995 Modelled IHME
23.8 (22.40 - 25) 1994 Modelled IHME
23 (21.70 - 24.10) 1993 Modelled IHME
22 (20.70 - 23) 1992 Modelled IHME
21 (19.80 - 22) 1991 Modelled IHME
20.2 (19.10 - 21.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
37,843 (31,786 - 41,392) 2019 Modelled IHME
37,558 (31,422 - 40,944) 2018 Modelled IHME
36,807 (30,885 - 40,097) 2017 Modelled IHME
36,581 (30,748 - 39,942) 2016 Modelled IHME
36,383 (30,467 - 39,590) 2015 Modelled IHME
36,644 (30,911 - 39,935) 2014 Modelled IHME
37,108 (31,489 - 40,371) 2013 Modelled IHME
37,549 (32,035 - 40,774) 2012 Modelled IHME
37,965 (32,603 - 41,156) 2011 Modelled IHME
37,992 (32,893 - 40,985) 2010 Modelled IHME
38,077 (33,159 - 40,895) 2009 Modelled IHME
38,590 (34,014 - 41,380) 2008 Modelled IHME
38,899 (34,565 - 41,571) 2007 Modelled IHME
39,037 (35,011 - 41,543) 2006 Modelled IHME
39,208 (35,360 - 41,632) 2005 Modelled IHME
38,711 (35,207 - 40,978) 2004 Modelled IHME
38,311 (34,854 - 40,490) 2003 Modelled IHME
37,600 (34,415 - 39,657) 2002 Modelled IHME
37,343 (34,374 - 39,314) 2001 Modelled IHME
37,295 (34,463 - 39,200) 2000 Modelled IHME
37,226 (34,468 - 39,161) 1999 Modelled IHME
36,186 (33,732 - 38,036) 1998 Modelled IHME
34,656 (32,481 - 36,417) 1997 Modelled IHME
33,494 (31,492 - 35,269) 1996 Modelled IHME
32,402 (30,463 - 34,004) 1995 Modelled IHME
30,336 (28,548 - 31,824) 1994 Modelled IHME
29,183 (27,521 - 30,634) 1993 Modelled IHME
27,818 (26,212 - 29,165) 1992 Modelled IHME
26,461 (24,941 - 27,753) 1991 Modelled IHME
25,401 (23,982 - 26,667) 1990 Modelled IHME
18,195 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
73 (69 - 75) 2019 Modelled IHME
73 (70 - 76) 2018 Modelled IHME
73 (70 - 76) 2017 Modelled IHME
73 (70 - 75) 2016 Modelled IHME
72 (69 - 75) 2015 Modelled IHME
72 (69 - 75) 2014 Modelled IHME
72 (69 - 75) 2013 Modelled IHME
72 (68 - 74) 2012 Modelled IHME
71 (68 - 74) 2011 Modelled IHME
71 (68 - 74) 2010 Modelled IHME
71 (68 - 74) 2009 Modelled IHME
71 (68 - 74) 2008 Modelled IHME
71 (68 - 74) 2007 Modelled IHME
71 (68 - 73) 2006 Modelled IHME
71 (68 - 73) 2005 Modelled IHME
70 (67 - 73) 2004 Modelled IHME
70 (67 - 73) 2003 Modelled IHME
70 (67 - 72) 2002 Modelled IHME
69 (66 - 72) 2001 Modelled IHME
69 (66 - 72) 2000 Modelled IHME
69 (66 - 71) 1999 Modelled IHME
68 (65 - 71) 1998 Modelled IHME
68 (65 - 71) 1997 Modelled IHME
68 (65 - 71) 1996 Modelled IHME
67 (64 - 70) 1995 Modelled IHME
67 (64 - 70) 1994 Modelled IHME
67 (64 - 70) 1993 Modelled IHME
66 (63 - 69) 1992 Modelled IHME
66 (63 - 69) 1991 Modelled IHME
65 (62 - 68) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HBV testing policy
Universal
HepB birth dose policy
Yes (for risk groups)
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
HCV testing policy
Universal
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
7,655
2019
(6,475 - 8,750)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
37,843
2019
(31,786 - 41,392)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines